- Home
- SABR vs INMD Comparison
SABR vs INMD Comparison
Compare SABR & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SABR | INMD |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 842.0M | 842.0M |
| IPO Year | 2014 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SABR | INMD |
|---|---|---|
| Price | $1.75 | $15.34 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 5 |
| Target Price | $1.50 | ★ $17.33 |
| AVG Volume (30 Days) | ★ 5.1M | 827.0K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 283.56 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $3,866,956,000.00 | N/A |
| Revenue This Year | $7.51 | $1.74 |
| Revenue Next Year | $3.46 | $3.26 |
| P/E Ratio | $86.00 | ★ $10.11 |
| Revenue Growth | ★ 7.46 | N/A |
| 52 Week Low | $0.81 | $12.72 |
| 52 Week High | $3.30 | $16.74 |
Technical Indicators
Market Signals| Indicator | SABR | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.80 | 63.09 |
| Support Level | $1.72 | $13.27 |
| Resistance Level | $1.99 | $15.72 |
| Average True Range (ATR) | 0.10 | 0.31 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 10.78 | 73.62 |
Price Performance
Historical ComparisonAbout SABR Sabre Corporation
Sabre holds the number-two air booking volume share in the global distribution system industry. The marketplace segment represented 80% of total 2025 revenue and airline technology solutions 20% of revenue. The company sold its growing hotel IT solutions division to TPG in 2025 for $960 million in net proceeds. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.